Antibiotic Resistant Bacteria: A Challenge to Modern Medicine 2019
DOI: 10.1007/978-981-13-9879-7_7
|View full text |Cite
|
Sign up to set email alerts
|

Extrinsic Antibiotic-Resistant Mechanism in Bacteria

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 88 publications
0
5
0
Order By: Relevance
“… 29 The occurrence of ciprofloxacin and imipenem resistance in E. coli is a concerning issue, since 1987 no new antibiotic has been discovered and imipenem is the last line of the drug to the gram-negative bacteria. 30 In the current study, the isolated E. coli E1 was resistant to various classes of antibiotics including imipenem. If the imipenem MDR bacteria continue to spread, it could be challenging to control the infection using a commercially available antibiotic.…”
Section: Resultsmentioning
confidence: 70%
“… 29 The occurrence of ciprofloxacin and imipenem resistance in E. coli is a concerning issue, since 1987 no new antibiotic has been discovered and imipenem is the last line of the drug to the gram-negative bacteria. 30 In the current study, the isolated E. coli E1 was resistant to various classes of antibiotics including imipenem. If the imipenem MDR bacteria continue to spread, it could be challenging to control the infection using a commercially available antibiotic.…”
Section: Resultsmentioning
confidence: 70%
“…Notwithstanding this, the efficacy and enduring consequences of these methodologies remain incompletely comprehended. 199 The management of diseases such as MT , PA , SA , and leishmaniasis represents an additional obstacle. Although niosomes and combination therapies have been suggested as potential approaches to address the issue of antibiotic resistance exhibited by biofilm-forming bacteria and drug-resistant MT , PA , and SA , respectively, the effectiveness of these treatments is still being studied.…”
Section: Treatment Of Infectionsmentioning
confidence: 99%
“…82 , 83 , 84 If these alternate models were already flawless, then why do we still have the antibiotic crisis or a lack of affordable drugs for Alzheimer's disease? 59 , 85 , 86 , 87 , 88 With such imperfect systems, untested drugs identified using them will pose a risk to patients, with pregnant patients being particularly vulnerable. 89 , 90 Even if a child is born with defects, in contrast to countries where social healthcare system and infrastructure are designed to support people with disabilities, the children most affected will be those in countries lacking such resources.…”
Section: Implications Of Animal Model Alternatives For Developing Nat...mentioning
confidence: 99%